258 related articles for article (PubMed ID: 35663937)
1. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas.
Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z
Front Immunol; 2022; 13():877815. PubMed ID: 35663937
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes.
Li Z; Yang W; Liu D; Ye W; Du G; Li X
Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer.
Yang Z; Li J; Tang Y; Zou L
Reprod Sci; 2023 Jun; 30(6):2003-2015. PubMed ID: 36576713
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
6. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
7. Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning.
Qi L; Chen F; Wang L; Yang Z; Zhang W; Li Z
Front Pharmacol; 2023; 14():1217488. PubMed ID: 37408763
[No Abstract] [Full Text] [Related]
8. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
Peng YL; Wang LX; Li MY; Liu LP; Li RS
PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
[TBL] [Abstract][Full Text] [Related]
9. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
[TBL] [Abstract][Full Text] [Related]
10. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
Xu L; Gao X; Xing J; Guo Z
Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
[TBL] [Abstract][Full Text] [Related]
11. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
12. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
Front Immunol; 2022; 13():964118. PubMed ID: 36059470
[TBL] [Abstract][Full Text] [Related]
13. A panel of necroptosis-related genes predicts the prognosis of pancreatic adenocarcinoma.
Luo Z; Wang L; Shang Z; Guo Q; Liu Q; Zhang M; Li T; Wang Y; Zhang Y; Zhang Y; Zhang X
Transl Oncol; 2022 Aug; 22():101462. PubMed ID: 35635957
[TBL] [Abstract][Full Text] [Related]
14. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.
Zhang Q; Zhu Z; Guan J; Zheng C
Front Oncol; 2022; 12():904614. PubMed ID: 35814424
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes.
Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
[TBL] [Abstract][Full Text] [Related]
18. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
20. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
Front Immunol; 2022; 13():999084. PubMed ID: 36544770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]